New Therapeutic Drug Monitoring Test for Interleukin‐23 Inhibitor SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, ...
More information: David P. Chimento et al, Bioanalytical Assays for Oligonucleotide Therapeutics: Adding Antibody-Based ...
Companion diagnostics support the shift toward precision medicine by using biomarker analysis to match patients to the most effective treatments. Recent advances in computational pathology have ...
Angle announced on Friday the successful completion of assay development projects for AstraZeneca and Eisai, further expanding its portfolio of liquid biopsy solutions and strengthening its position ...
An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...
Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback